Research articleZinc oxide nanoparticles (ZnO NP) mediated regulation of bacosides biosynthesis and transcriptional correlation of HMG-CoA reductase gene in suspension culture of Bacopa monnieri
-
Add time:08/25/2019 Source:sciencedirect.com
Bacopa monnieri (L.) Wettst. is a well documented nootropic plant, extensive known for alleviating symptoms of neurological disorder, along with other symptomatic relief. This property is attributed to the active phytocompounds, saponins (bacoside A) present in the plant. However, lack of stringent validation guidelines in most of the countries bring to the market, formulations differing in phytocompounds yield, thereby suggesting possible variation in therapeutic efficacy. The in-vitro suspension cultures of the Bacopa monnieri, provide an ease of scale-up, but regulating saponin yield is a stringent task. The aim of the study is to explore the effects of different concentrations (0, 0.25, 0.50, 0.75 and 1.0 ppm) of zinc oxide nanoparticles (ZnO NP) (24 nm in size), in regulating growth rate, bacoside yield and transcriptional profile of HMG CoA reductase gene in the suspension cells of Bacopa monnieri. Results showed a linear correlation between Bacoside A yield and ZnO NP concentrations with around 2 fold increase in total bacoside A concentration at 1 ppm. Also, ZnO NP supplemented suspension cells showed variation in the specific growth rate. Neuroprotective properties, analyzed using methanolic extracts of suspension cells again obtrude the extract of ZnO NP supplemented (0.75 ppm and 1 ppm) culture for better response in alleviating oxidative stress mediated damage to neuronal cells. ZnO NP supplemented system showed lower expression of HMG CoA reductase gene (the rate limiting step in bacoside A biosynthesis) but higher concentration of bacoside A, suggesting possible role of ZnO NP in isoprenoid pathway than MVA pathways.
We also recommend Trading Suppliers and Manufacturers of BACOSIDE A (cas 11028-00-5). Pls Click Website Link as below: cas 11028-00-5 suppliers
Prev:Production of BACOSIDE A (cas 11028-00-5), a memory enhancer from hairy root cultures of Bacopa monnieri (L.) Wettst
Next:Research PaperClinical and histological features of brucellin (cas 11028-17-4) skin test responses in Brucella suis biovar 2 infected pigs) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Production of BACOSIDE A (cas 11028-00-5), a memory enhancer from hairy root cultures of Bacopa monnieri (L.) Wettst08/24/2019
- Bacoside-A, an anti-amyloid natural substance, inhibits membrane disruption by the amyloidogenic determinant of prion protein through accelerating fibril formation08/23/2019
- Surface modified PLGA nanoparticles for brain targeting of Bacoside-A08/22/2019
- Enhanced bacoside content in polyamine treated in-vitro raised Bacopa monnieri (L.) Wettst08/21/2019
- Elite genotypes of Bacopa monnieri, with high contents of BACOSIDE A (cas 11028-00-5) and Bacopaside I, from southern Western Ghats in India08/20/2019
- BACOSIDE A (cas 11028-00-5) and bromelain relieve dichlorvos induced changes in oxidative responses in mice serum08/19/2019
- Protective propensity of BACOSIDE A (cas 11028-00-5) and bromelain on renal cholinesterases, γ-Aminobutyric acid and serotonin level of Mus musculus intoxicated with dichlorvos08/18/2019
- Attenuation of cytotoxicity induced by tBHP in H9C2 cells by Bacopa monniera and BACOSIDE A (cas 11028-00-5)08/17/2019
- Bacoside-A inhibits inflammatory cytokines and chemokine in experimental autoimmune encephalomyelitis08/16/2019


